These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16915258)

  • 21. Market watch: Sales of biologics to show robust growth through to 2013.
    Goodman M
    Nat Rev Drug Discov; 2009 Nov; 8(11):837. PubMed ID: 19876035
    [No Abstract]   [Full Text] [Related]  

  • 22. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The art of mismanagement.
    Nat Biotechnol; 2006 Nov; 24(11):1300. PubMed ID: 17093455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 25. Payers, consumers benefit as patents expire.
    Manag Care; 2006 Sep; 15(9):72. PubMed ID: 17036942
    [No Abstract]   [Full Text] [Related]  

  • 26. GlaxoSmithKline, Pfizer to merge HIV drug units in new company.
    AIDS Read; 2009; 19(6):206. PubMed ID: 19642236
    [No Abstract]   [Full Text] [Related]  

  • 27. Pfizer: DM did not fizzle in Florida Medicaid ruckus.
    Carroll J
    Manag Care; 2004 Sep; 13(9):10, 12. PubMed ID: 15490673
    [No Abstract]   [Full Text] [Related]  

  • 28. How many patents does a biopharmaceutical company need?
    Parida DK; Mehdiratta R; Saberwal G
    Nat Biotechnol; 2008 Jul; 26(7):763-6. PubMed ID: 18612295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysts see 'tale of two CEOs' unfolding at Pfizer and Merck.
    Hutson S
    Nat Med; 2011 Feb; 17(2):140. PubMed ID: 21297589
    [No Abstract]   [Full Text] [Related]  

  • 30. Copycat consolidation.
    Wadman M
    Nature; 2007 Sep; 449(7161):393. PubMed ID: 17898741
    [No Abstract]   [Full Text] [Related]  

  • 31. ArQule-Pfizer deal breaks mold.
    Dorey E
    Nat Biotechnol; 1999 Sep; 17(9):843-4. PubMed ID: 10471914
    [No Abstract]   [Full Text] [Related]  

  • 32. The quiet revolution: outsourcing in pharma.
    Crossley R
    Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
    [No Abstract]   [Full Text] [Related]  

  • 33. Indian pharma enters the global arena.
    Singh S
    Cell; 2007 Mar; 128(5):811-4. PubMed ID: 17350563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cheap at any price?
    Ledford H
    Nature; 2007 May; 447(7141):131. PubMed ID: 17495898
    [No Abstract]   [Full Text] [Related]  

  • 35. The Health Impact Fund: boosting pharmaceutical innovation without obstructing free access.
    Pogge T
    Camb Q Healthc Ethics; 2009; 18(1):78-86. PubMed ID: 19091149
    [No Abstract]   [Full Text] [Related]  

  • 36. A place in the sun.
    Abbott A
    Nature; 2007 Mar; 446(7132):124-5. PubMed ID: 17344823
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug patents distort research].
    Magnusson PA
    Lakartidningen; 2008 Apr 2-8; 105(14):1032. PubMed ID: 18478758
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug industry's misuse of patents must be prevented].
    Magnusson PA
    Lakartidningen; 2008 Feb 20-26; 105(8):555. PubMed ID: 18363299
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug executives should take a Hippocratic oath.
    More B
    Nature; 2018 Mar; 555(7698):561. PubMed ID: 29595775
    [No Abstract]   [Full Text] [Related]  

  • 40. When there's no room to grow.
    Ledford H
    Nature; 2008 Jul; 454(7201):144-5. PubMed ID: 18615042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.